Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05448560 · ClinicalTrials.gov registry record · NA

A Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship

A NA study of Survivorship and Health Knowledge, Attitudes, Practice, sponsored by Georgetown University.

Active
Registry status
NA
Development phase
240
Enrollment target
4
Study locations

NCT05448560: Active NA study of Survivorship and Health Knowledge, Attitudes, Practice, sponsored by Georgetown University.

NCT05448560 is a NA study of Survivorship and Health Knowledge, Attitudes, Practice that is active but no longer recruiting, run by Georgetown University. The registered enrollment target is 240 participants, roughly in line with the 224-participant average among 36 other Survivorship trials with a reported enrollment target. The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05448560, a NA study of Survivorship and Health Knowledge, Attitudes, Practice, is active but no longer recruiting, sponsored by Georgetown University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
4
Study locations

Study Summary

More than 80% of childhood cancer survivors develop serious or life-threatening late effects after cancer therapy, but \<20% receive recommended survivorship care offered at cancer center survivorship clinics. In a shared care model, the investigators propose to investigate an innovative multi-level intervention consisting of: 1) patient survivorship education via telehealth with the cancer center, 2) ongoing patient-tailored education program within the electronic health record patient portal, 3) a structured interactive phone communication between the cancer center and the primary care clinic, and 4) an in-person visit with the primary care clinic for survivorship care with the goal of achieving high rates of adherence to recommended surveillance for late effects, as well as improving patient and physician knowledge and self-efficacy. If this scalable intervention demonstrates patient completion of recommended care comparable to cancer center survivorship clinics, this innovative study has the enormous potential to deliver recommended care to a larger proportion of childhood cancer survivors and reduce survivorship care disparities, while engaging p to integrate survivorship care as part of overall, lifelong health maintenance.

Primary Outcome

The investigators will assess adherence to surveillance recommended by the Children's Oncology Group Long-term Follow-up Guidelines. The primary analysis will be on tests completed by patients, and not just ordered by physicians, because that is the most meaningful indicator of patient adherence to guidelines

Interventions

  • BEHAVIORAL Multi-level Intervention of shared model of survivorship care
  • OTHER Comparison Group

Study Locations (4)

California

  • MemorialCare Miller Children's & Women's Hospital Long Beach - Long Beach

Colorado

  • Children's Hospital Colorado - Denver

New Jersey

  • Hackensack University Medical Center - Hackensack

North Carolina

  • University of North Carolina Children's Hospital - Chapel Hill

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2023-01-01
Est. Completion 2026-08-31
Phase NA
Georgetown University

227 total trials

What the registry record for NCT05448560 still lists

NCT05448560 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 224-participant average among 36 other Survivorship trials with a reported enrollment target.

The record links to 5 conditions, with Survivorship appearing as the primary indexed condition, and to 2 interventions - of which Multi-level Intervention of shared model of survivorship care is the first listed.

NCT05448560 reports a single indexed study location in California, Colorado, New Jersey.

Frequently Asked Questions

What is clinical trial NCT05448560 about?

NCT05448560 is a clinical study titled "A Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship". More than 80% of childhood cancer survivors develop serious or life-threatening late effects after cancer therapy, but \<20% receive recommended survivorship care offered at cancer center survivorship clinics. In a shared care model, the investigators propose to investigate an innovative multi-level...

What is the current status of trial NCT05448560?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2023-01-01. Estimated completion is 2026-08-31.

What conditions does trial NCT05448560 study?

This clinical trial studies the following conditions: Survivorship, Health Knowledge, Attitudes, Practice, Health Care Utilization, Childhood Cancer, Adherence, Patient.

What interventions are being tested in trial NCT05448560?

The interventions under investigation include: Multi-level Intervention of shared model of survivorship care (BEHAVIORAL), Comparison Group (OTHER).

Who is sponsoring clinical trial NCT05448560?

This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05448560 being conducted?

This trial has 4 study locations across California, Colorado, New Jersey, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Survivorship

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05448560's enrollment target sits among peer trials

240 11th of 36 higher than 26 of 36 other Survivorship trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Survivorship trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02855554 · 240 participants · NA

    Quantitative Cardiac Parametric Mapping

  • NCT03230565 · 240 participants · Phase 4

    Continuous Infusions vs Scheduled Bolus Infusions

  • NCT03399929 · 240 participants

    Traumatic Brain Injury and Stroke Long Term Outcome

  • NCT03583710 · 240 participants · Phase 3

    Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05448560, the US trial registry maintained by the National Library of Medicine. NCT05448560 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.